Streetbeat News

AQB

AquaBounty Technologies, Inc.

https://www.aquabounty.com

Industry

Agricultural Farm Products

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.

Open

1.02

Mkt cap

3.9M

Volume

19K

High

1.02

P/E Ratio

-0.05

52-wk high

4.03

Low

1.00

Div yield

N/A

52-wk low

0.81

AquaBounty Techs (NASDAQ:AQB) reported Q4 earnings with an EPS of $-2.19, missing estimates by -43.0% against an expected $-1.53. Revenue increased by $102 thousand from the same period last year. The company's past earnings performance shows a mixed trend with a notable 10.0% drop in share price following last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 2:50 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. Palisade Bio (PALI) saw a 66% increase, while Aptorum Gr (APM) rose by 18.88%. NovaBay Pharmaceuticals (NBY), MyMD Pharmaceuticals (MYMD), NuCana (NCNA), and Asensus Surgical (ASXC) also posted gains. Conversely, Acutus Medical (AFIB), Aclarion (ACON), Inspire Veterinary (IVP), HeartBeam (BEAT), Panbela Therapeutics (PBLA), and AquaBounty Techs (AQB) experienced declines.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:31 pm

In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Kura Oncology (KURA) saw a substantial rise of 39.6%, while Redhill Biopharma (RDHL) and Akanda (AKAN) also posted notable gains. Conversely, AquaBounty Techs (AQB) and vTv Therapeutics (VTVT) were among the stocks that faced declines. The movements reflect changes in the market value of these companies' outstanding shares.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 1:05 pm

In Monday's intraday session, several healthcare stocks experienced significant movements. Sagimet Biosciences (SGMT) saw a notable increase of 103.5%, while Virios Therapeutics (VIRI) led the decliners with a 37.1% drop. Other gainers included Bullfrog AI Hldgs (BFRG), Bone Biologics (BBLG), 60 Degrees (SXTP), AquaBounty Techs (AQB), and BIMI Intl Medical (BIMI). On the losing side were Shuttle Pharmaceuticals (SHPH), NexImmune (NEXI), Synaptogenix (SNPX), CNS Pharma (CNSP), and Elicio Therapeutics (ELTX).

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 5:31 pm

In Thursday's after-market session, several healthcare stocks experienced significant movements. Gainers included cbdMD (YCBD), CEL-SCI (CVM), DermTech (DMTK), China Pharma Holding (CPHI), Accuray (ARAY), and Yield10 Bioscience (YTEN), with increases ranging from 5.08% to 16.5%. Losers comprised Cingulate (CING), Microbot Medical (MBOT), T2 Biosystems (TTOO), SenesTech (SNES), NKGen Biotech (NKGN), and AquaBounty Techs (AQB), with declines between 6.15% and 14.9%.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:31 pm

In Monday's after-market session, several healthcare stocks experienced significant movements. Connect Biopharma Hldgs (CNTB) saw a 51.1% increase, while IN8bio (INAB) rose by 14.84%, and Inotiv (NOTV) by 13.85% following their Q4 earnings release. OneMedNet (ONMD), AquaBounty Techs (AQB), and Cue Health (HLTH) also saw gains. Conversely, Assure Hldgs (IONM), Pasithea Therapeutics (KTTA), Lucy Scientific Discovery (LSDI), Onconova Therapeutics (ONTX), Exicure (XCUR), and NRX Pharmaceuticals (NRXP) experienced declines.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 9:31 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Intensity Therapeutics (INTS) saw a notable increase of 107.2%, while Conduit Pharmaceuticals (CDT) and ALX Oncology Holdings (ALXO) also saw substantial gains. On the other hand, AquaBounty Techs (AQB), Veradigm (MDRX), and Cano Health (CANO) were among the stocks that declined. These movements reflect the dynamic nature of the healthcare sector and may be influenced by company-specific news or broader market trends.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 5:31 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. Impel Pharmaceuticals (IMPL) saw a dramatic increase of 141.4%, while Entrada Therapeutics (TRDA) faced a sharp decline of 33.1%. Other notable gainers include Conduit Pharmaceuticals (CDT), Telesis Bio (TBIO), AquaBounty Techs (AQB), PaxMedica (PXMD), and Seelos Therapeutics (SEEL). On the losing side, Alterity Therapeutics (ATHE), GRI Bio (GRI), Inspire Veterinary (IVP), Altamira Therapeutics (CYTO), and Mira Pharmaceuticals (MIRA) saw their stock prices fall.

Portfolio Pulse from Benzinga Insights

November 23, 2023 | 5:31 pm

HC Wainwright & Co. analyst Kevin Dede has downgraded AquaBounty Techs (NASDAQ:AQB) from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:49 pm

Oppenheimer analyst Colin Rusch has downgraded AquaBounty Techs (NASDAQ:AQB) from Outperform to Perform.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:53 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.